Chemoinformaics analysis of RUGOSIN-E
Molecular Weight | 1723.21 | nRot | 15 |
Heavy Atom Molecular Weight | 1668.78 | nRig | 87 |
Exact Molecular Weight | 1722.18 | nRing | 12 |
Solubility: LogS | -1.609 | nHRing | 3 |
Solubility: LogP | 2.06 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 9 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 177 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 123 | No. of Aromatic Carbocycles | 9 |
nHetero | 48 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 75 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 54 |
No. of Oxygen atom | 48 | No. of Arom Bond | 54 |
nHA | 48 | APOL | 199.753 |
nHD | 27 | BPOL | 81.9492 |
QED | 0.03 |
Synth | 5.967 |
Natural Product Likeliness | 0.899 |
NR-PPAR-gamma | 0.008 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.147 |
Pgp-sub | 0 |
HIA | 1 |
CACO-2 | -7.844 |
MDCK | 0.00000357 |
BBB | 0 |
PPB | 0.90359 |
VDSS | -0.221 |
FU | 2.70027 |
CYP1A2-inh | 0.021 |
CYP1A2-sub | 0 |
CYP2c19-inh | 0.002 |
CYP2c19-sub | 0.003 |
CYP2c9-inh | 0.069 |
CYP2c9-sub | 0.001 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.014 |
CYP3a4-inh | 0 |
CYP3a4-sub | 0 |
CL | 11.669 |
T12 | 0.993 |
hERG | 0.002 |
Ames | 0.014 |
ROA | 0 |
SkinSen | 0.979 |
Carcinogencity | 0 |
EI | 0.974 |
Respiratory | 0 |
NR-Aromatase | 0.056 |
Antiviral | Yes |
Prediction | 0.704938 |